Salesforce Ventures was part of a consortium that supplied $11m for the tech sales training provider in a round led by E.ventures.

The Oxford-linked oncology drug developer has raised the money from new and existing backers, and will use the cash to boost its product pipeline.

Johnson & Johnson Innovation – JJDC has co-led the computational pathology technology provider's series C round to take its total funding to $195m.

The Amazon-based food delivery app developer bumped its valuation up to $7bn in a series H round co-led by Fidelity and Durable Capital Partners.

Citi Ventures has participated in the software deployment platform provider’s latest funding round, which lifted its valuation to $1.7bn.

Burda Principal Investments returned for a series D round that lifted flower delivery service Bloom & Wild's total funding to at least $130m.

The Eli Lilly and Wuxi AppTec-backed oncology drug developer has raised the money from new and existing backers, and will use the cash to boost its product pipeline.

Johnson & Johnson Innovation – JJDC co-led the computational pathology technology provider's series C round to take its total funding to $195m.

The Alibaba-backed rail network software developer pushed its overall funding near the $130m mark in a round led by Sanno Capital.

University of Michigan and Virginia-founded Everactive has reached its series C target after three tranches.